Back to News
Market Impact: 0.3

Bear of the Day: Flowers Foods (FLO)

FLONOMDINGRNVDANDAQ
Corporate EarningsAnalyst EstimatesCompany FundamentalsConsumer Demand & RetailInvestor Sentiment & PositioningAnalyst Insights
Bear of the Day: Flowers Foods (FLO)

Flowers Foods (FLO), a major U.S. packaged-bakery company (Nature’s Own, Dave’s Killer Bread, Wonder), is being flagged by Zacks as a #5 (Strong Sell) after five analyst cuts in the past 60 days drove the Zacks consensus down from $1.18 to $1.10 for the current year and from $1.27 to $1.14 for next year—implying a 14% earnings contraction this year and only 3.6% growth next year. With the Food—Miscellaneous industry in the bottom 27% of Zacks’ industry rankings, the revision activity underscores weakening earnings momentum and sector headwinds that could continue to pressure FLO versus higher-ranked peers like Nomad Foods and Ingredion.

Analysis

Zacks Investment Research has flagged Flowers Foods (FLO) as a Zacks Rank #5 (Strong Sell) after five analyst cuts over the past 60 days reduced the Zacks Consensus Estimate for the current year from $1.18 to $1.10 and next year’s estimate from $1.27 to $1.14. Those revisions translate in Zacks’ framing to an implied 14% earnings contraction this year and only 3.6% growth next year for a company that owns brands such as Nature’s Own, Dave’s Killer Bread and Wonder Bread. The article frames the cuts as a material shift in earnings momentum rather than a temporary demand blip. The Food — Miscellaneous industry sits in the bottom 27% of Zacks’ Industry Rank, and per-ticker sentiment is strongly negative for FLO (per-ticker sentiment -0.8) with an overall moderately negative tone (sentiment_score -0.6). Zacks highlights higher-ranked peers (Nomad Foods, Zacks #1, and Ingredion, Zacks #2) as alternatives, implying relative weakness for Flowers versus select packaged-food names. The stated market impact score is low (0.3), suggesting limited systemic market ripple but material idiosyncratic risk for holders of FLO. Immediate implications are increased downside risk from further estimate downgrades and potential margin pressure; conversely, stabilization of estimates or positive guidance would be a necessary catalyst to change the negative view. Investors should watch upcoming earnings, guidance and incremental analyst revisions as the primary indicators that could alter the current negative outlook.